Target intelligence / Profile preview

Ovulation suppression

Molecular classification
Other
01

Overview

Ovulation suppression refers to the pharmacological or physiological inhibition of ovulation, primarily achieved by suppressing the secretion of gonadotropins (LH and FSH) from the anterior pituitary gland. This is a key mechanism in hormonal contraception, medical therapy for PCOS, and assisted reproductive technologies. Suppression may be accomplished with estrogens, progestins, GnRH agonists, or GnRH antagonists, each acting via distinct effects on the hypothalamic-pituitary-ovarian axis. Drugs that suppress ovulation may act by directly inhibiting LH and FSH secretion, preventing follicle maturation, or blocking the mid-cycle LH surge required for ovulation[2][3]

Other names
ovulation inhibitioninhibition of ovulationsuppression of ovulation
02

Mechanism of action

Inhibition of gonadotropin secretion from the pituitary (LH and FSH), inhibition of follicular development, disruption of LH surge, maintenance of hormone levels that prevent ovulatory signals[2][3]

03

Biological functions

Prevention of ovulationinhibition of follicular maturationsuppression of LH and FSH secretion
04

Disease associations

Other (includes use in contraception, PCOS management, assisted reproductive technologies)
05

Safety considerations

Disrupted menstrual cycleshypoestrogenismpotential bone mineral density loss (with GnRH analogs)altered lipid metabolismthromboembolic risk (with estrogen-containing therapies)[2][3]
06

Interacting drugs

Estrogens

3 more in the full profile.

07

Biomarkers

Low luteal-phase progesteroneabsence of LH surgefailure of ovarian follicle maturationP4 < 5 ng/mL as a surrogate marker for suppressive effect[2]

Beyond the preview

Go deeper on Ovulation suppression.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ovulation suppression.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call